Pharmacokinetics of Intravenous Immunoglobulin and Outcome of Guillain-Barre Syndrome

J Gordon Millichap

doi:10.15844/pedneurbriefs-24-1-10

Pharmacokinetics of Intravenous Immunoglobulin and Outcome of Guillain-Barre Syndrome

Pediatric Neurology Briefs

Volume 24 (2010): Issue 1

By: J Gordon Millichap

Open Access

|Jan 2010

Abstract

The relation of pharmacokinetics of intravenous immunoglobulin (IVIg) to the outcome of Guillain-Barre syndrome (GBS) was determined in 174 adults treated at Erasmus Medical Center, Rotterdam, The Netherlands.

References

Kuitwaard K de Gelder J Tio-Gillen AP Hop WC van Gelder T van Toorenenbergen AW Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barre syndrome Ann Neurol 2009 Nov 66 5 597 603 10.1002/ana.21737 19938102
Open DOI Search in Google Scholar Back to article
Cornblath DR Hughes RA Treatment for Guillain-Barré syndrome Ann Neurol 2009 Nov 66 5 569 570 10.1002/ana.21816 19938064
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-24-1-10 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 8 - 8

Published on: Jan 1, 2010

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Intravenous Immunoglobulin,

Guillain-Barre Syndrome,

IVIg Pharmacokinetics

© 2010 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 24 (2010): Issue 1